Use Elan Corporation plc story together with your portfolio to enhance returns of your portfolios and to determine Stock optimization strategy that fits your criteria.
This story from stocks.us.reuters.com contributed to next trading day price increase. The story delta to the next closing price was 0.29% . The story delta to the current price is 4.39% .
By Brian Orelli, The Motley Fool Gilenya was supposed to be the multiple sclerosis front runner, taking market share from treatments that have to be injected or infused because it's taken orally.
By Sean Williams , The Motley Fool Shares of Biogen Idec (NAS: BIIB) hit a 52-week high today. Let's take a look at how the company got there and whether clear skies are still in the forecast.
Elan Corp. (NYSE: ELN)'s stock had its ?buy? rating reiterated by equities research analysts at Jefferies Group (NYSE: JEF) in a research note issued to investors on Tuesday.
Elan Corp (ELN) Up on Positive FDA Alzheimer's Disease Comments - StreetInsider.com (subscription)
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
